United States: FDA Issues Draft Guidance On General Wellness Devices And On Medical Device Accessories

Last Updated: February 5 2015
Article by James Cohen, Daniel Gottlieb and Michael W. Ryan

On January 16, 2015, the U.S. Food and Drug Administration (FDA) posted a draft guidance document outlining the FDA's proposed approach to the regulation of general wellness devices (Draft General Wellness Guidance) under the Federal Food Drug and Cosmetic Act (FD&C Act), and a separate draft guidance document regarding its approach to the regulation of medical device accessories (Draft Accessories Guidance) under the FD&C Act.

Although the draft guidance documents apply to a broad range of medical devices, they are notable because they are the latest in a series of FDA guidance documents intended to address mobile health applications and other health information technology (IT).  These draft guidance documents follow on the heels of the FDA's 2013 final guidance on the regulation of mobile medical applications, and 2014's health IT report pursuant to the Food and Drug Administration Safety and Innovation Act (FDASIA) and draft guidance announcing enforcement discretion for manufacturers of medical device data systems. 

The draft guidance documents address two of the five topics on which the FDASIA Health IT Working Group recommended that the FDA provide greater clarity regarding the extent to which a particular mobile medical application or other medical product will be subject to FDA's medical device regulatory oversight and controls.  The guidance thus provides insights to software developers, manufacturers and other stakeholders that wish to design mobile applications and other health IT products in a manner that avoids the need for time-consuming and expensive premarket filings and related regulatory requirements.

Stakeholders should consider submitting comments to the FDA regarding the draft guidance documents.  The official comment period for both draft guidance documents closes on April 20, 2015.

This On the Subject addresses the following key issues raised by the guidance documents: 

In the Draft General Wellness Guidance:

  • What is a "general wellness product"?
  • How would a product with a general wellness use be regulated if it falls outside the draft guidance (i.e., because it is not deemed low risk)?

In the Draft Accessories Guidance:

  • What is a medical device "accessory"?
  • How does the FDA propose to classify medical device accessories?
  • What FD&C Act regulatory requirements apply to the potential classifications of accessories?

Draft General Wellness Guidance

The Draft General Wellness Guidance states that the FDA does not intend to regulate low-risk "general wellness products" as devices under the FD&C Act.  Even if a low-risk general wellness product might meet the statutory definition of a "device," the FDA does not intend to assess whether a general wellness product's sponsor complies with the regulatory requirements applicable to device manufacturers (e.g., registration and listing, premarket notification, labeling, good manufacturing practice requirements and medical device reporting).

What is a general wellness product?

The Draft General Wellness Guidance defines a general wellness product as a product that meets both of the following criteria:

  • It is intended only for general wellness use.
  • It presents a very low risk to user safety.

What is a general wellness use?

For the purposes of the first criterion, a general wellness use is an intended use that either relates to maintaining or encouraging a general state of health or a healthy activity, or associates the role of a healthy lifestyle with helping to reduce the risk or impact of certain chronic diseases or conditions where it is well understood and accepted that healthy lifestyle choices may play an important role in health outcomes for the disease or condition.

A product's intended use "relates to maintaining or encouraging a general state of health or a healthy activity" if the product's sponsor claims the product sustains or generally improves conditions and functions associated with a general state of health, and such claims do not make any reference to diseases or conditions.  This first category of general wellness intended uses relates to weight management, physical fitness, relaxation or stress management, mental acuity, self-esteem, sleep management or sexual function.  The following are examples of this first category of general wellness claims:

  • To promote or maintain a healthy weight, encourage healthy eating or assist with weight loss goals
  • To promote relaxation or manage stress when there is no reference to anxiety disorders or other references to a disease or condition
  • To promote physical fitness, such as by helping log, track or trend exercise activity; measure aerobic fitness; improve physical fitness; develop or improve endurance, strength or coordination; or improve energy
  • To address a specific body structure or function, such as increasing or improving muscle size or body tone, toning or firming the body or muscle, enhancing cardiac function, or enhancing or improving sexual performance
  • To enhance an individual's participation in recreational activities by monitoring the consequences of participating in such activities, such as by monitoring heart rate or monitoring frequency or impact of collisions

The Draft General Wellness Guidance states that the following claims would not fall within the category of general wellness claims:

  • To treat or diagnose obesity
  • To treat an eating disorder, such as anorexia
  • To treat anxiety
  • To diagnose or treat autism
  • To treat muscle atrophy or erectile dysfunction 
  • To restore a structure or function impaired as a result of a disease (e.g., a claim that a prosthetic device enables amputees to play basketball)

A "product associates the role of a healthy lifestyle with helping to reduce the risk or impact of certain chronic diseases or conditions" if it promotes, tracks and/or encourages choices that, as a part of a healthy lifestyle, may help to reduce the risk of, or help people to live well with, certain chronic diseases or conditions.  Disease-related claims should only contain references where it is well understood that healthy lifestyle choices may reduce the risk or impact of a chronic disease or medical condition.  The following are examples of this second category of general wellness claims:

  • To promote physical activity, which, as part of a healthy lifestyle, may help reduce the risk of high blood pressure
  • To track caloric intake and help manage a healthy eating plan, which may help to maintain a healthy weight and balanced diet, and living well with high blood pressure or type 2 diabetes
  • To track sleep activity patterns and promote healthy sleep habits, which, as part of a healthy lifestyle, may help reduce the risk of developing type 2 diabetes

When does a product present more than a very low risk to user safety?

For purposes of the second criterion, the FDA cautions that the policy decision to not regulate certain general wellness products does not extend to devices that present an inherent risk to user safety.  Products intended for a general wellness use that are invasive, involve an intervention or technology that may pose a risk to a user's safety if regulatory device controls are not applied, raise novel questions or usability, and/or raise questions of biocompatibility would not meet the criteria for non-regulation under the Draft General Wellness Guidance.

The following are examples of products that present inherent risks to a user's safety and would not be considered low-risk:

  • Sunlamp products promoted for tanning purposes (because of risks associated with exposure to ultraviolet radiation)
  • Implants promoted for improved self image or sexual function (because of risk of rupture or adverse reaction to implant materials or implantation procedure)
  • Lasers that claim to improve confidence in users' appearance by rejuvenating the skin (because of risk of skin and eye burns, as well as usability considerations that may be addressed with labeling and other design controls)

Decision Algorithm for General Wellness Products

The following flowchart summarizes the process for determining whether a product is a low-risk general wellness product for the purposes of the Draft General Wellness Guidance:

How would a product with a general wellness use be regulated if it falls outside the draft guidance?

A product that falls outside the scope of the Draft General Wellness Guidance (i.e., because it is not deemed low risk) and meets the FD&C Act's definition of a medical device may be regulated as such by the FDA.  The FDA states that the sponsor(s) of products subject to regulation as a medical device must comply with the FDA's registration and listing, premarket notification, labeling, good manufacturing practice and medical device reporting requirements, among others. 

Key Takeaways

Manufacturers of general wellness products—including mobile medical application developers and other mobile health technologies (e.g., exercise activity trackers, pulse monitors)—will welcome the clear non-regulation position proposed in the Draft General Wellness Guidance, particularly with respect to devices that make well-established claims relating to specific diseases or conditions.  The Draft General Wellness Guidance does not address several other health-IT-related topics of interest, however (including devices that incorporate invasive technologies, clinical decision support software built into electronic health record systems, and other health IT), so developers should monitor future health-IT-related FDA guidance.

Draft Accessories Guidance

In the Draft Accessories Guidance, the FDA clarifies when it intends to consider a product an "accessory" and how its risk-based classification framework applies to accessories of other medical devices.

What is a medical device "accessory"?

The Draft Accessories Guidance defines an "accessory" as a "device that is intended to support, supplement and/or augment the performance of one or more parent devices."

  • A device supports the performance of a parent device by enabling or facilitating that device to perform according to its intended use.
  • A device supplements the performance of a parent device if it adds a new function or a new way of using the parent device without changing the intended use of the parent device.
  • A device augments the performance of a parent device by enabling the device to perform its intended use more safely or effectively.

Examples of device accessories include the following:

  • A mobile application that controls a medical device (e.g., applications that provide the ability to control inflation and deflation of a blood pressure cuff, or to control the delivery of insulin on an insulin pump by submitting control signals) is an accessory.
  • A pulse oximeter is an accessory when it allows a mobile application intended for use in active patient monitoring to display oxygen saturation statistics but does not alter the application's intended use (i.e., to record and display multiple physiological parameters).
  • A rechargeable battery is an accessory when it is intended to operate when paired with an automated external defibrillator.
  • A tool for the placement of an implantable nerve stimulator is an accessory when it is intended to augment the performance of the stimulator by facilitating its successful placement.

How does the FDA propose to classify medical device accessories?

Classifying an accessory in the same regulatory class as its parent medical device is appropriate when the accessory, when used as intended, meets the FDA's criteria for placement in that device class.  However, the FDA notes that some accessories may have a lower risk profile than their parent device and therefore may warrant being regulated in a lower class and being subject to fewer regulatory controls.  Because accessories are intended to be used with and to support, supplement and/or augment one or more parent devices, the FDA proposes to assess the risk of accessories when used as intended with the parent device type. 

Under the Draft Accessories Guidance, the FDA does not necessarily impute all of the risks associated with a parent medical device to an accessory; the FDA specifically acknowledges that the risk profile of an accessory may differ substantially from that of the parent device, warranting differences in regulatory classification.  In determining the classification of an accessory, the FDA will evaluate the risks imposed by the accessory's impact on the parent device and any unique risks of the accessory independent of its parent device.  Depending on the FDA's assessment of these risks, the accessory may be subject to different regulatory requirements and controls, such as premarket clearance notification or approval, current good manufacturing practice requirements, labeling and postmarket safety reporting, among other requirements.

The Draft Accessories Guidance encourages manufacturers and other submitters to utilize the de novo classification process to request the risk-based classification of new types of accessories.  Under the de novo process, if a submitter demonstrates that general regulatory controls (or general and special regulatory controls) provide a reasonable assurance of safety and effectiveness for an accessory, the FDA will grant the request and classify the accessory in Class I or Class II.  The accessory may then be marketed immediately and serve as a predicate device for future Section "510(k)" premarket clearance notifications.  If the de novo request is declined, however, the FDA notes that the accessory remains in Class III and may not be marketed until premarket approval is obtained.

Key Takeaways

The Draft Accessories Guidance is notable in that the FDA indicates its willingness to apply a different level of regulatory scrutiny to certain medical device accessories—including, potentially, mobile applications that support, supplement or augment a parent medical device—than it does to the parent device itself.  The draft guidance does not provide any specific examples of how this process might apply to health IT products, however, and puts the onus on manufacturers to file a regulatory de novo petition with the FDA to seek "a risk-based classification of new types of accessories."  Therefore, the extent to which the draft guidance heralds a change in the FDA's regulatory position remains to be seen.

FDA Issues Draft Guidance On General Wellness Devices And On Medical Device Accessories

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
McDermott Will & Emery
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
McDermott Will & Emery
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions